ACE2 and TMPRSS2 Immunolocalization and COVID-19-Related Thyroid Disorder

ACE2 and TMPRSS2 Immunolocalization and COVID-19-Related Thyroid Disorder

Thyroid dysfunction has been reported to be an extrapulmonary symptom of COVID-19. It is important to identify the tissue subset that expresses angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2), which are essential for host infection with severe acute respiratory s...

Full description

Bibliographic Details
Main Authors:	Gi-Cheol Park, Hyoun-Wook Lee, Ji-Min Kim, Ji-Min Han, Hye-In Kim, Sung-Chan Shin, Yong-il Cheon, Eui-Suk Sung, Minhyung Lee, Jin-Choon Lee, Dong-Min Shin, Byung-Joo Lee
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biology
Subjects:	ACE2 TMPRSS2 COVID-19 SARS-CoV-2 thyroid
Online Access:	https://www.mdpi.com/2079-7737/11/5/697

Similar Items

The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity
by: Zorana Dobrijević, et al.
Published: (2022-06-01)

Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
by: Nazanin Zounemat Kermani, et al.
Published: (2021-01-01)

ACE2 and TMPRSS2 genetic polymorphisms as potential predictors of COVID−19 severity and outcome in females
by: Sanja Matic, et al.
Published: (2024-12-01)

Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester
by: Bailey A. T. Weatherbee, et al.
Published: (2020-08-01)

Salivary ACE2 and TMPRSS2 link to periodontal status and metabolic parameters
by: Dan Zhao, et al.
Published: (2022-03-01)

ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
by: Akçahan GEPDİREMEN, et al.
Published: (2020-12-01)

ACE2 and TMPRSS2 expression in patients before, during, and after SARS-CoV-2 infection
by: Henrique Borges da Silva Grisard, et al.
Published: (2024-03-01)

Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection
by: Shima Shahbaz, et al.
Published: (2022-11-01)

Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers
by: He C, et al.
Published: (2021-03-01)

Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
by: Marwa H. Elnagdy, et al.
Published: (2024-01-01)

Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
by: Silvia Martinez-Diz, et al.
Published: (2023-06-01)

Expression Pattern of the SARS-CoV-2 Entry Genes <i>ACE2</i> and <i>TMPRSS2</i> in the Respiratory Tract
by: Yichuan Liu, et al.
Published: (2020-10-01)

High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
by: Qianqian Wang, et al.
Published: (2021-05-01)

The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences
by: Ayelet Barash, et al.
Published: (2020-10-01)

Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
by: Jingwei Li, et al.
Published: (2022-02-01)

Improved efficacy of SARS-CoV-2 isolation from COVID-19 clinical specimens using VeroE6 cells overexpressing TMPRSS2 and human ACE2
by: Hitomi Kinoshita, et al.
Published: (2024-10-01)

Variations in levels of ACE2 and TMPRSS2 receptors among COVID-19
by: Dalia Zanaty, et al.
Published: (2024-02-01)

Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19
by: Hsin-Hsien Li, et al.
Published: (2021-03-01)

Role of ACE2 and TMPRSS2 polymorphisms in clinical severity and outcomes of COVID-19 in Egypt
by: Walaa Samy, et al.
Published: (2024-08-01)

A Plausible Link of TMPRSS2/ACE2/AR Signaling to Male Mortality during the COVID-19 Pandemic in the United States
by: Lilly M. Wong, et al.
Published: (2021-10-01)

Altered plasma levels of the SARS-CoV-2-related proteins ACE2 and TMPRSS2 in patients with Crohn’s disease
by: Jorge Sáez-Leyva, et al.
Published: (2024-12-01)

Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD
by: Narjes Saheb Sharif-Askari, et al.
Published: (2020-09-01)

Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
by: Alexandra Lindsey Zune Djomkam, et al.
Published: (2020-08-01)

The Important Role of TMPRSS2 Gene in Covid-19 and Prostate Cancer: In Silico Approach
by: Arif Kalkanli, et al.
Published: (2021-11-01)

ACE2 and TMPRSS2 distribution in the respiratory tract of different animal species and its correlation with SARS-CoV-2 tissue tropism
by: Mariano Carossino, et al.
Published: (2024-02-01)

Hydrogen Sulfide Inhibits TMPRSS2 in Human Airway Epithelial Cells: Implications for SARS-CoV-2 Infection
by: Giulia Pozzi, et al.
Published: (2021-09-01)

Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2
by: Hongwei Liu, et al.
Published: (2024-07-01)

Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis
by: Debasmita Mukhopadhyay, et al.
Published: (2020-09-01)

A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants
by: Ching-Wen Chang, et al.
Published: (2022-06-01)

Estudio piloto de la co-expresión en membrana plasmática de las Proteínas celulares receptora (ACE2) y modificadora (TMPRSS2) de SARSCOV-2 en mucosa oral sana y con enfermedad periodontal
by: Ana Cristina Soto, et al.
Published: (2023-03-01)

Estudio piloto de la co-expresión en membrana plasmática de las Proteínas celulares receptora (ACE2) y modificadora (TMPRSS2) de SARSCOV-2 en mucosa oral sana y con enfermedad periodontal
by: Ana Cristina Soto, et al.
Published: (2023-03-01)

Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators
by: Eirini Gkogkou, et al.
Published: (2020-09-01)

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
by: Si Zhang, et al.
Published: (2020-09-01)

Immunocytochemical Assessment of ACE2 and TMPRSS2 in Nasopharyngeal Swabs from SARS-CoV-2 Patients
by: Karla Beatríz Peña, et al.
Published: (2022-07-01)

Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion
by: Mei Zheng, et al.
Published: (2020-01-01)

Association between tissue stress reaction and ACE2/TMPRSS2 expression in endometria of reproductive aged women before and during Covid-19 pandemic
by: Kanae Ogawa, et al.
Published: (2023-05-01)

TMPRSS2 Impacts Cytokine Expression in Murine Dendritic Cells
by: Sandra Gunne, et al.
Published: (2023-02-01)

Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells
by: Jonathan J. Hernandez, et al.
Published: (2021-04-01)

A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunityResearch in context
by: Fernanda Ana-Sosa-Batiz, et al.
Published: (2025-03-01)

Human-SARS-CoV-2 interactome and human genetic diversity: TMPRSS2-rs2070788, associated with severe influenza, and its population genetics caveats in Native Americans
by: Fernanda S.G. Kehdy, et al.
Published: (2021-08-01)